Preventing hepatitis C virus infection in injection drug users: Risk reduction is not enough

AIDS

Volumn 21, Issue 14, 2007, Pages 1967-1969

  Page Shafer, Kimberly ^a   Hahn, Judith A ^a   Lum, Paula J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHAMPHETAMINE;

DRUG DEPENDENCE; DRUG USE; EDITORIAL; HEPATITIS C; HUMAN; INFECTION PREVENTION; INFECTION RISK; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PATIENT EDUCATION; PRIORITY JOURNAL; SEXUAL BEHAVIOR; VIRUS TRANSMISSION;

HEALTH EDUCATION; HEPATITIS C; HUMANS; PREVALENCE; RISK REDUCTION BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; VIRAL HEPATITIS VACCINES;

EID: 34548207851     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282ef7701     Document Type: Editorial

References (16)

1. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45:529-538.
2. Global Burden of Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004; 44: 20-29.
3. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144:705-714.
4. Centers for Disease Control and Prevention. Hepatitis Surveillance Report, 61. Atlanta, GA: Centers for Disease Control and Prevention; 2006.
5. Garfein RS, Bailey S, Golub ET, Greenberg A, Hagan H, Hanson DL, et al. for the DUIT Study Team. Reduction in injection risk behaviors for HIV and HCV infection among young injection drug users using a peer-education intervention. AIDS 2007; 20:000-000.
6. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996; 86:655-661.
7. Hahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology 2001; 34:180-187.
8. Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet 1997; 349:1797-1800.
9. Murray JM, Law MG, Gao Z, Kaldor JM. The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users. Int J Epidemiol 2003; 32:708-714.
10. Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis 2002; 186:1558-1564.
11. Page-Shafer K, Lum P, Hahn J, Evans J, Cooper S, Tobler L, et al. Effective detection of acute hepatitis C infection using RNA screening and antibody testing in young injectors in San Francisco: the UFO Study. 13th Conference on Retroviruses and Opportunistic Infections. Denver, February 2006 [abstract 844].
12. Kral AH, Page-Shafer K, Edlin BR, Kellogg T, Riley E, Gee L, et al. Persistent HIV incidence among injection drug users in San Francisco during the 1990s: results of five studies. J Acquir Immune Defic Syndr 2004; 37:1667-1669.
13. Wright NM, Tompkins CN. A review of the evidence for the effectiveness of primary prevention interventions for Hepatitis C among injecting drug users. Harm Reduct J 2006; 3:27.
14. Hagan H, Thiede H, Des Jarlais DC. Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion. Epidemiology 2004; 15:543-549.
15. Kamal SM, Fouly AE, Kamel RR, Hockenjos B, Al Tawil A, Khalifa KE, et al. Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response. Gastroenterology 2006; 130:632-638.
16. Hagan H, Latka MH, Campbell JV, Golub ET, Garfein RS, Thomas DA, et al. Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities. Clin Infect Dis 2006; 42:669-672.